Next Article in Journal
Noninvasive Prediction of Advanced Fibrosis in Pediatric Liver Disease—Discriminatory Performance of 2D Shear Wave Elastography, Transient Elastography and Magnetic Resonance Elastography in Comparison to Histopathology
Previous Article in Journal
Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese
 
 
Article
Peer-Review Record

The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus-Restricted Atrophic Gastritis

Diagnostics 2022, 12(11), 2784; https://doi.org/10.3390/diagnostics12112784
by Petra Kriķe 1,2,*, Zakera Shums 3, Inese Poļaka 1, Ilze Kikuste 4, Aigars Vanags 4, Ivars Tolmanis 4, Sergejs Isajevs 5, Inta Liepniece-Karele 6, Daiga Santare 1,7, Lilian Tzivian 1, Dace Rudzīte 7, Minkyo Song 8, M. Constanza Camargo 8, Gary L. Norman 3 and Mārcis Leja 1,4,7
Reviewer 1:
Reviewer 2: Anonymous
Diagnostics 2022, 12(11), 2784; https://doi.org/10.3390/diagnostics12112784
Submission received: 25 October 2022 / Revised: 10 November 2022 / Accepted: 11 November 2022 / Published: 14 November 2022
(This article belongs to the Section Pathology and Molecular Diagnostics)

Round 1

Reviewer 1 Report

The paper "The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus Restricted Atrophic Gastritis" is extremely up-to-date, as there are many discussion about the diagnosis of CRAG, gastritis that can induce the gastric cancer. The methodology is sound, the results are presented in very well interpreted tables, the discussions are covering the topic. The conclusions are coherent to the data obtained in the study.

However, I would suggest more discussion about the HP, as approximately half of the patients had also the infection.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The current research shows important relationship of serum anti-PCA, anti-IFA, PG, G-17 and Hp-IgG with gastric atrophy, which is cancer related. The style and design are OK and the results reliable. There are some minor issues to be concerned.

1.H.pylori's positive rate by serum and pathology is opposite in CRAG and control group. Do we need UBT for the tests?

2.The sample size is not big enough.

3. Some reports on PG, G-17 and Hp were missed in the literature, including but not limited to Gut 2019;68:1576–1587, Gut 2021;70:829–837., Gastroenterology Research and Practice Volume 2022, Article ID 7639968, Gastric Cancer (2021) 24:1194–1202, etc.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop